Corvus Pharmaceuticals Inc. (C17)
Market Open
11 Aug, 20:00
XSTU 
€
12. 64
+0.84
+7.1156%
€
- Market Cap
- P/E Ratio
- Div Yield
760 Volume
-0.55 Eps
€ 11.8
Previous Close Want to track C17 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
C17 Earnings Reports FAQ
What is the earnings per share (EPS) for C17?
The current EPS is -0.55.
What is the company's earnings growth rate?
Corvus Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Corvus Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Corvus Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for C17 at this time, as Corvus Pharmaceuticals Inc has no recent EPS data to calculate it.
